Literature DB >> 23620136

Helical domains that mediate lipid solubilization and ABCA1-specific cholesterol efflux in apolipoproteins C-I and A-II.

Loren E Smith1, Jere P Segrest, W Sean Davidson.   

Abstract

Many of the apolipoproteins in HDL can elicit cholesterol efflux via ABCA1, a critical initial step in HDL formation. Recent work has indicated that omnipresent amphipathic helices play a critical role, and these have been studied intensively in the most common HDL protein, apolipoprotein (apo)A-I. However, little information exists about helical domain arrangement in other apolipoproteins. We studied two of the smallest apolipoproteins known to interact with ABCA1, human apoA-II and apoC-I, in terms of ability to reorganize phospholipid (PL) bilayers and to promote ABCA1-mediated cholesterol. We found that both proteins contained helical domains that were fast and slow with respect to solubilizing PL. ABCA1-medated efflux required a minimum of a bihelical polypeptide comprised of at least one each of a slow and fast lipid reorganizing domain. In both proteins, the fast helix was located at the C terminus preceded by a slow helix. Helical placement in apoC-I was not critical for ABCA1 activity, but helix swaps in apoA-II dramatically disrupted cholesterol efflux, indicating that the tertiary structure of the longer apolipoprotein is important for the pathway. This work has implications for a more complete molecular understanding of apolipoprotein-mediated cholesterol efflux.

Entities:  

Keywords:  amphipathic helix; apolipoprotein-mediated cholesterol efflux; tertiary structure

Mesh:

Substances:

Year:  2013        PMID: 23620136      PMCID: PMC3679395          DOI: 10.1194/jlr.M037903

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

1.  The interaction of human apolipoprotein C-I with sub-micellar phospholipid.

Authors:  B W Atcliffe; C A MacRaild; P R Gooley; G J Howlett
Journal:  Eur J Biochem       Date:  2001-05

2.  Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.

Authors:  A T Remaley; J A Stonik; S J Demosky; E B Neufeld; A V Bocharov; T G Vishnyakova; T L Eggerman; A P Patterson; N J Duverger; S Santamarina-Fojo; H B Brewer
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

3.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

4.  Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.

Authors:  Robert J Aiello; Dominique Brees; Patricia-Ann Bourassa; Lori Royer; Saralyn Lindsey; Timothy Coskran; Mehrdad Haghpassand; Omar L Francone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

5.  Solution conformation of human apolipoprotein C-1 inferred from proline mutagenesis: far- and near-UV CD study.

Authors:  O Gursky
Journal:  Biochemistry       Date:  2001-10-09       Impact factor: 3.162

6.  The role of apolipoprotein AI domains in lipid binding.

Authors:  W S Davidson; T Hazlett; W W Mantulin; A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1.

Authors:  Pradeep Natarajan; Trudy M Forte; Berbie Chu; Michael C Phillips; John F Oram; John K Bielicki
Journal:  J Biol Chem       Date:  2004-03-29       Impact factor: 5.157

8.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

Authors:  Nan Wang; Wengen Chen; Patrick Linsel-Nitschke; Laurent O Martinez; Birgit Agerholm-Larsen; David L Silver; Alan R Tall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.

Authors:  Alan T Remaley; Fairwell Thomas; John A Stonik; Steve J Demosky; Samantha E Bark; Edward B Neufeld; Alexander V Bocharov; Tatyana G Vishnyakova; Amy P Patterson; Thomas L Eggerman; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Lipid Res       Date:  2003-01-16       Impact factor: 5.922

10.  The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.

Authors:  Stacey E Panagotopulos; Scott R Witting; Erica M Horace; David Y Hui; J Nicholas Maiorano; W Sean Davidson
Journal:  J Biol Chem       Date:  2002-08-13       Impact factor: 5.157

View more
  14 in total

1.  The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.

Authors:  Kohjiro Nagao; Mami Hata; Kento Tanaka; Yuki Takechi; David Nguyen; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochim Biophys Acta       Date:  2013-10-09

2.  Proteogenomic Review of the Changes in Primate apoC-I during Evolution.

Authors:  Donald Puppione; Julian P Whitelegge
Journal:  Front Biol (Beijing)       Date:  2013-10-02

3.  Development and application of a high throughput one-pot extraction protocol for quantitative LC-MS/MS analysis of phospholipids in serum and lipoprotein fractions in normolipidemic and dyslipidemic subjects.

Authors:  Michael S Gardner; Zsuzsanna Kuklenyik; Antony Lehtikoski; Kayla A Carter; Lisa G McWilliams; Jennifer Kusovschi; Kevin Bierbaum; Jeffrey I Jones; Jon Rees; Gregory Reis; James L Pirkle; John R Barr
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-04-22       Impact factor: 3.205

4.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

5.  Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma.

Authors:  Debi K Swertfeger; Hailong Li; Sandra Rebholz; Xiaoting Zhu; Amy S Shah; W Sean Davidson; Long J Lu
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

6.  Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.

Authors:  Detao Gao; Eugene A Podrez
Journal:  Free Radic Biol Med       Date:  2017-11-15       Impact factor: 7.376

7.  From a Highly Disordered to a Metastable State: Uncovering Insights of α-Synuclein.

Authors:  Yoann Cote; Patrice Delarue; Harold A Scheraga; Patrick Senet; Gia G Maisuradze
Journal:  ACS Chem Neurosci       Date:  2018-02-26       Impact factor: 4.418

8.  Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis.

Authors:  Michelle W Lee; Elizabeth Wei-Chia Luo; Carlos Silvestre-Roig; Yashes Srinivasan; Kiyotaka Akabori; Patricia Lemnitzer; Nathan W Schmidt; Ghee Hwee Lai; Christian D Santangelo; Oliver Soehnlein; Gerard C L Wong
Journal:  ACS Nano       Date:  2021-09-29       Impact factor: 15.881

9.  MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice.

Authors:  Joan Cheng; Angela Cheng; Bethan L Clifford; Xiaohui Wu; Ulf Hedin; Lars Maegdefessel; Nathalie Pamir; Tamer Sallam; Elizabeth J Tarling; Thomas Q de Aguiar Vallim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 10.514

10.  Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in ANGPTL3.

Authors:  Laura F Michael; Joanne E Curran; Nicholas B Blackburn; Peter J Meikle; Juan M Peralta; Satish Kumar; Ana C Leandro; Melissa A Bellinger; Corey Giles; Kevin Huynh; Michael C Mahaney; Harald H H Göring; John L VandeBerg; Sarah Williams-Blangero; David C Glahn; Ravindranath Duggirala; John Blangero
Journal:  Circ Genom Precis Med       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.